Showing posts with label Duchenne muscular dystrophy. Show all posts
Showing posts with label Duchenne muscular dystrophy. Show all posts

Friday, 13 October 2023

Organic Osmolytes and Duchenne Muscular Dystrophy: From Homeostasis, Inflammation and Skeletal Muscle Regeneration to Therapeutic Target| Chapter 11 | Novel Research Aspects in Medicine and Medical Science Vol. 7

 In this study, we pay particular consideration to the PKA-p38MAPK-NFAT5-organic osmolytes pathway, that involves protein kinase A, mitogen-activated protein kinase, basic factor of triggered T cells 5, and organic osmolytes. Through allure control of the inflow and outflow of natural osmolytes, this route contributes significantly to the osmotic balance inevitable for optimal cell function. Duchenne burly dystrophy (DMD) is not only one of ultimate severe forms of inherited vigorous dystrophies but also the most universal hereditary neuromuscular disease. In Duchenne sturdy dystrophy (DMD), the absence of dystrophin from the dystrophin- befriended protein complex (DAPC) causes muscle membrane imbalance, which leads to myofiber necrosis, restricted regeneration, and chronic redness. The resulting disabled DAPC-joined cellular pathways have existed described both at the microscopic and the therapeutical level, with the Toll-like receptor basic factor kappa-light-chain-enhancer of activated B containers pathway (NF-KB), Janus kinase/signal transducer and activator of copy proteins, and the transforming progress factor-β pathways receiving ultimate attention. Besides, NFAT5 plays an essential role in container survival under hyperosmolar conditions, in wasted muscle conversion, and in tissue inflammation, carefully interacting with the master manager of inflammation NF-KB. We describe the difficulty of the PKA-p38MAPK- NFAT5-organic osmolytes pathway in DMD pathophysiology and determine a clear overview of that therapeutic molecules maybe of potential benefit to DMD patients. We conclude that timbre of the PKA-p38MAPK-NFAT5-organic osmolytes pathway maybe developed as supportive situation for DMD in conjunction with hereditary therapy.

Author(s) Details:

Sandrine Herbelet,
Department of Head and Skin, Ghent University and Ghent University Hospital, C. Heymanslaan 10, 9000 Ghent, Belgium.

Caroline Merckx,
Department of Neurology, Ghent University and Ghent University Hospital, C. Heymanslaan 10, 9000 Ghent, Belgium.

Boel De Paepe,
Department of Neurology, Ghent University and Ghent University Hospital, C. Heymanslaan 10, 9000 Ghent, Belgium and Neuromuscular Reference Center, Ghent University Hospital, C. Heymanslaan 10, 9000 Ghent, Belgium.

Please see the link here: https://stm.bookpi.org/NRAMMS-V7/article/view/12175 

Thursday, 16 December 2021

Duchenne Muscular Dystrophy Fibrosis Potentially Explained by Abnormal NFAT5 Physiology in Duchenne Muscular Dystrophy Fibroblasts | Chapter 8 | New Innovations in Chemistry and Biochemistry Vol. 5

 Chronic inflammation and fibrotic tissue development by fibroblasts characterise Duchenne muscular dystrophy (DMD). Nuclear factor of activated T-cells 5 (NFAT5), a promyogenic factor that responds to hyperosmolar or pro-inflammatory stress, is essentially present in all cells. The lack of NFAT5 causes cell cycle arrest in embryogenic fibroblasts. The goal of this investigation was to see how hyperosmolar or pro-inflammatory stress altered NFAT5 in unaffected and DMD fibroblasts. Unaffected skeletal muscle fibroblasts from one healthy donor demonstrated NFAT5 nuclear translocation and normal cell survival when exposed to hyperosmolar stress. Under pro-inflammatory conditions, the absence of NFAT5 translocation resulted in a reduction in cell proliferation (Incucyte ZOOM). NFAT5 was only found in the nucleus of one DMD patient's skeletal muscle fibroblasts. The physiology of NFAT5 was unaffected by hyperosmolar circumstances or pro-inflammatory cytokines IFN-, IL-1, and TNF- (immunofluorescence, western blotting, RT-qPCR). In undisturbed cell development, hyperosmolarity resulted in lower cell viability and pro-inflammatory stress. These data imply that NFAT5 is required for the survival of DMD fibroblasts. When DMD fibroblasts are exposed to pro-inflammatory or hyperosmolar stress, an unexpected NFAT5 response occurs, in which fibroblasts are not triggered by inflammatory cytokines and cannot resist hyperosmolarity. Chronic inflammation may play a non-restrictive role in the development of fibrosis in DMD. Permanent fibrotic matrix synthesis by DMD cells could be explained molecularly by abnormal NFAT5 physiology.


Author(S) Details

Sandrine Herbelet
Department of Neurology, Ghent University and Ghent University Hospital, C. Heymanslaan 10, 9000 Ghent, Belgium.

Boel De Paepe
Department of Neurology, Ghent University and Ghent University Hospital, C. Heymanslaan 10, 9000 Ghent, Belgium and Neuromuscular Reference Center, Ghent University Hospital, C. Heymanslaan 10, 9000 Ghent, Belgium.

Jan L. De Bleecker
Department of Neurology, Ghent University and Ghent University Hospital, C. Heymanslaan 10, 9000 Ghent, Belgium and Neuromuscular Reference Center, Ghent University Hospital, C. Heymanslaan 10, 9000 Ghent, Belgium.

View Book:- https://stm.bookpi.org/NICB-V5/article/view/5149

Monday, 12 July 2021

Study of NFAT5 Physiology in Duchenne Muscular Dystrophy Fibroblasts: Provisionary Explanation for the Permanent Fibrosis Formation in Duchenne Muscular Dystrophy | Chapter 6 | Recent Research Advances in Biology Vol. 9

 Chronic inflammation and fibrotic tissue development by fibroblasts characterise Duchenne muscular dystrophy (DMD). Nuclear factor of activated T-cells 5 (NFAT5), a promyogenic factor that responds to hyperosmolar or pro-inflammatory stress, is essentially present in all cells. The lack of NFAT5 causes cell cycle arrest in embryogenic fibroblasts. Unaffected skeletal muscle fibroblasts from one healthy donor demonstrated NFAT5 nuclear translocation and normal cell survival when exposed to hyperosmolar stress. Under pro-inflammatory conditions, the absence of NFAT5 translocation resulted in a reduction in cell proliferation (Incucyte ZOOM). In one DMD patient's skeletal muscle fibroblasts, The nucleus was the only place where NFAT5 was found. The physiology of NFAT5 was unaffected by hyperosmolar circumstances or pro-inflammatory cytokines IFN-, IL-1, and TNF- (immunofluorescence, western blotting, RT-qPCR). In undisturbed cell development, hyperosmolarity resulted in lower cell viability and pro-inflammatory stress. These data imply that NFAT5 is required for the survival of DMD fibroblasts. When DMD fibroblasts are exposed to pro-inflammatory or hyperosmolar stress, an unexpected NFAT5 response occurs, in which fibroblasts are not triggered by inflammatory cytokines and cannot resist hyperosmolarity. Chronic inflammation can be thought of as a non-restrictive element in the development of cancer. Fibrosis is a complication of DMD. Permanent fibrotic matrix synthesis by DMD cells could be explained molecularly by abnormal NFAT5 physiology.

 
Author (s) Details

Sandrine Herbelet
Department of Neurology, Ghent University and Ghent University Hospital, C. Heymanslaan 10, 9000 Ghent, Belgium.

Boel De Paepe
Department of Neurology, Ghent University and Ghent University Hospital, C. Heymanslaan 10, 9000 Ghent, Belgium and Neuromuscular Reference Center, Ghent University Hospital, C. Heymanslaan 10, 9000 Ghent, Belgium.

Jan L. De Bleecker
Department of Neurology, Ghent University and Ghent University Hospital, C. Heymanslaan 10, 9000 Ghent, Belgium and Neuromuscular Reference Center, Ghent University Hospital, C. Heymanslaan 10, 9000 Ghent, Belgium.

View Book :- https://stm.bookpi.org/RRAB-V9/article/view/2007